Brief: Argent Biopharma Says FDA-CVM Established Inad File For Cannepil Veterinary Program
26/08/2026 02:37
BRIEF-Argent Biopharma Says FDA-CVM Established Inad File For Cannepil Veterinary Program Aug 26 (Reuters) - Argent BioPharma Ltd RGT.AX:
FDA-CVM ESTABLISH INAD FILE FOR CANNEPIL VETERINARY PROGRAM
FDA-CVM ESTABLISHES INAD FILE NO. 14145 FOR CANNEPIL
Further company coverage: RGT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Executes Global Licence For Non-Core Cannabis Genetics
Brief: Argent Biopharma Files Provisional US Patent On Immune Modulation And Longevity
Australia's Argent BioPharma rises to over 1-month high on new licence agreement
Brief: Argent Biopharma Signs NLC Licence To Expand Antiviral Portfolio
Brief: Argent Biopharma Says FDA-CVM Established Inad File For Cannepil Veterinary Program